Impact of addition of BMS-275291 to paclitaxel/carboplatin examined in phase II/III trial in NSCLC Oct. 26, 2001
Combination of CCI-779 and 5-FU/LV associated with significant toxicity in phase I study Oct. 26, 2001
Series of selective COX-2 inhibitors useful for wide range of disorders according to recent patent Oct. 25, 2001
RSS